Clinical Trials Logo

Lung Diseases, Obstructive clinical trials

View clinical trials related to Lung Diseases, Obstructive.

Filter by:

NCT ID: NCT05922241 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Comparative Effects of Costophrenic Assisted Cough and Anterior Chest Compression Technique in COPD Patients

Start date: June 15, 2023
Phase: N/A
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. In Costophrenic assist, the therapist gives a quick stretch to the diaphragm and intercostals with repetitions. The patientt holds air in the lungs. As the patient gets ready to cough, the therapist performs a diaphragmatic assist. In Anterior chest compression: the therapist places one arm across the patient's pectorals and the other parallel to it. After the patient takes a maximal breath, the therapist pushes down to help the patient cough. The greatest force is applied through the lower chest during expulsion. A total 34 patients will be taken. 2 groups will be created to apply intervention. After signing consent form, 17 patients in group A will be given costophrenic assist technique and 17 patients in group B will be given anterior chest compression technique. Baseline treatment given to both groups will include percussion and tapping. The data collected will then be analyzed using IBM SPSS version 25

NCT ID: NCT05918731 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Self-management in Chronic Obstructive Pulmonary Disease (COPD) Patients Compared to Usual Care

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Evaluation of the effectiveness of COPD self-management interventions compared to usual on Quality of life, functional status, patient education, depression, and anxiety in primary healthcare users in the prefecture of Heraklion, Greece.

NCT ID: NCT05885152 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Acute Effect of Whole-body Electrical Stimulation in COPD Patients

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

Patients with chronic respiratory diseases present in addition to respiratory symptoms, peripheral muscle dysfunction, which contributes to functional impairment. The aim of the study is to investigate the safety of whole-body electrical stimulation in patients with chronic obstructive pulmonary disease (COPD). Patients will perform two whole body electrostimulation protocols, with an interval of one week between them. The primary outcome will be the safety of electrical stimulation through peripheral oxygen saturation, respiratory rate, systolic blood pressure, diastolic blood pressure, heart rate, dyspnea and fatigue (Borg subjective perceived exertion scale), autonomic control (rate variability cardiac arrest) and occurrence of adverse events. Secondary outcomes will be muscle damage assessed by serum creatine kinase level, muscle fatigue assessed by serum lactate level, delayed onset muscle soreness assessed by visual numerical scale, and peripheral muscle strength by dynamometry.

NCT ID: NCT05838911 Completed - Clinical trials for Pulmonary Rehabilitation

Does Neuromuscular Electrical Stimulation Benefit the Functional Ability of Elderly Patients With Chronic Obstructive Lung Disease

NEMS for COPD
Start date: April 2, 2023
Phase: N/A
Study type: Interventional

Background: Patients with COPD often experience skeletal muscle dysfunction. For those who are unable or unwilling to undertake physical training, neuromuscular electrical stimulation (NMES) may provide an alternative method of exercise training. Objective: To investigate the effects of adding neuromuscular electrical stimulation of gluteus maximus, quadriceps and calf muscles to chest physiotherapy, compared to chest physiotherapy alone, on muscles strength (gluteus max., quadriceps, calf muscles), femoral blood flow physical and pulmonary function in severe COPD Patients.

NCT ID: NCT05830071 Completed - Asthma Clinical Trials

A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)

Start date: March 29, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the potential for cardiac repolarization, according to electrocardiographic monitoring (including QT and QTc intervals), of two dose levels of CHF5993 pMDI (beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB)) and of one dose of CHF5259 (GB) in healthy subjects compared to moxifloxacin and placebo.

NCT ID: NCT05781867 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Selective Manual Therapy Techniques in Chronic Obstructive Pulmonary Disease

Start date: March 20, 2023
Phase: N/A
Study type: Interventional

Our study aiming for determining the combined effect of selective manual therapy techniques in chronic obstructive pulmonary disease patients

NCT ID: NCT05776654 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)

Start date: February 16, 2023
Phase:
Study type: Observational

The purpose the study is to successfully characterize the recovery phase of acute exacerbations of COPD in the outpatient setting using remotely captured physiologic data from wearable devices, to compare this with patient self-reported symptom data, to determine which physiologic variable(s) best correspond with AECOPD recovery, and to further document the feasibility, data quantity, data quality, and COPD outpatient usability experience with wearable devices.

NCT ID: NCT05771506 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Determinants of Balance in Patients With Chronic Obstructive Pulmonary Disease

Start date: January 1, 2023
Phase:
Study type: Observational

The primary aim of our study is to examine the relationship between balance and respiratory function, respiratory and peripheral muscle strength, functional capacity, and cognitive function in patients with Chronic Obstructive Pulmonary Disease (COPD). The secondary aim of our study is to compare respiratory function, respiratory and peripheral muscle strength, functional capacity, balance, and cognitive functions of COPD patients and healthy individuals. This study will examine and record the participant's sociodemographic information and medical records. Balance, respiratory function, respiratory and peripheral muscle strength, functional capacity, and cognitive function will be assessed. Since the patients are included in this study, no intervention will be made, no additional tests will be performed, or no changes will be made in the routine treatments of the patients during the study.

NCT ID: NCT05758428 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Nebulized Ensifentrine in Healthy Chinese Subjects

Start date: March 6, 2023
Phase: Phase 1
Study type: Interventional

This is a phase 1, open-label, parallel cohort study to evaluate the PK, safety and tolerability of nebulized ensifentrine following administration of single and multiple doses in healthy Chinese male subjects.

NCT ID: NCT05723302 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Diseases and Proprioceptive Neuromuscular Facilitation

Start date: January 20, 2017
Phase: N/A
Study type: Interventional

To investigate the effects of resistant proprioceptive neuromuscular facilitation exercises on physical fitness, respiratory muscle strength, walking distance and quality of life in chronic obstructive pulmonary patients.